Synergistic inhibition of SARS-coronavirus replication by type I and type II IFN

Advances in Experimental Medicine and Biology

Volumn 581, Issue , 2006, Pages 503-506

  Mossel, Eric C ^a   Sainz Jr , Bruno ^b   Garry, Robert F ^c   Peters, C J ^d  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934442250     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-33012-9_89     Document Type: Conference Paper

References (16)

1. Haagmans, B. L., Kuiken, T., Martina, B. E., Fouchier, R. A., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D., de Jong, T., Itamura, S., Chan, K. H., Tashiro, M., and Osterhaus, A. D., 2004, Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques, Nat. Med. 10:290-293.
2. Loutfy, M. R., Blatt, L. M., Siminovitch, K. A., Ward, S., Wolff, B., Lho, H., Pham, D. H., Deif, H., LaMere, E. A., Chang, M., Kain, K. C., Farcas, G. A., Ferguson, P., Latchford, M., Levy, G., Dennis, J. W., Lai, E. K., and Fish, E. N., 2003, Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study, JAMA 290:3222-3228.
3. Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., and Doerr, H. W., 2003, Treatment of SARS with human interferons, Lancet 362:293-294.
4. Hensley, L. E., Fritz, L. E., Jahrling, P. B., Karp, C. L., Huggins, J. W., and Geisbert, T. W., 2004, Interferon-beta 1a and SARS coronavirus replication, Emerg. Infect. Dis. 10:317-319.
5. Scagnolari, C., Vicenzi, E., Bellomi, F., Stillitano, M. G., Pinna, D., Poli, G., Clementi, M., Dianzani, F., and Antonelli, G., 2004, Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons, Antivir. Ther. 9:1003-1011.
6. Spiegel, M., Pichlmair, A., Muhlberger, E., Haller, O., and Weber, F., 2004, The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein, J. Clin. Virol. 30:211-213.
7. Stroher, U., DiCaro, A., Li, Y., Strong, J. E., Aoki, F., Plummer, F., Jones, S. M., and Feldmann, H., 2004, Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha, J. Infect. Dis. 189:1164-1167.
8. Asper, M., Sternsdorf, T., Hass, M., Drosten, C., Rhode, A., Schmitz, H., and Gunther, S., 2004, Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus, J. Virol. 78:3162-3169.
9. Czarniecki, C. W., Fennie, C. W., Powers, D. B., and Estell, D. A., 1984, Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons, J. Virol. 49:490-496.
10. Fleischmann, W. R., Jr., Georgiades, J. A., Osborne, L. C., and Johnson, H. M., 1979, Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon, Infect. Immun. 26:248-253.
11. Sainz, Jr., B., and Halford, W. P., 2002, Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1, J. Virol. 76:11541-11550.
12. Schwarz, L. A., Fleischmann, C. M., and Fleischmann, Jr., W. R., 1984, Potentiation of interferon's antiviral activity by the mutually synergistic interaction of MuIFN-alpha/beta and MuIFN-gamma, J. Biol. Response Mod. 3:608-612.
13. Sainz, Jr., B., Mossel, E. C., Peters, C. J., and Garry, R. F., 2004, Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV), Virology 329:11-17.
14. Sainz, Jr., B., Lamarca, H. L., Garry, R. F., and Morris, C. A., 2005, Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma, Virol. J. 2:14.
15. Akerstrom, S., Mousavi-Jazi, M., Klingstrom, J., Leijon, M., Lundkvist, A., and Mirazimi, A., 2005, Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus, J. Virol. 79:1966-1969.
16. Sekellick, M. J., Lowenthal, J. W., O'Neil, T. E., and Marcus, P. I., 1998, Chicken interferon types I and II enhance synergistically the antiviral state and nitric oxide secretion, J. Interferon Cytokine Res. 18:407-414.